MTC2017_BlogHeader_1030x130v3ALT.jpg

 

 

Matt Wetzel

Vice President & Assistant General Counsel at AdvaMed
Find me on:

Recent Posts

Ethical Codes Bolster an Industry’s Public Perception

Posted by Matt Wetzel on June 8, 2017

Note: this blog post was originally published on LinkedIn Pulse on February 14, 2017.

A commitment to the core values of patient care and innovation serves as medtech’s heartbeat.  The people who work in the medtech industry are committed to delivering high-quality care and good patient outcomes every day. They understand that what they do has a direct and positive impact on patients’ lives. They understand that their work contributes to the development of breakthrough technology. And they understand that the products they make could one day be used to save or improve the life of a loved one.  

Read More

Reflections On the U.S. Supreme Court’s Decision Limiting Use of the False Claims Act

Posted by Matt Wetzel on May 30, 2017

Note: this blog post was originally published on LinkedIn Pulse on January 11, 2017. 

In reflecting on 2016 legal developments, a key health law case that stands out is the Supreme Court’s decision endorsing the implied certification theory of the False Claims Act (Universal Health Services v. Escobar). Contrary to many press outlets, Universal Health Services will not serve – in 2017 and onward – to pave the way for more whistleblower suits. In fact, the Court’s decision raises the bar for whistleblowers, and its practical impact will be to restrict the use of the False Claims Act.

 

Read More